# Ampio Pharmaceuticals (stock symbol: AMPE) Logo in transparent PNG format

## Ampio Pharmaceuticals Logo large

### Ampio Pharmaceuticals Logo large Download PNG (27.97 KB)

![Ampio Pharmaceuticals Logo large Download PNG (27.97 KB)](/img/orig/AMPE_BIG-13116370.png)

## Ampio Pharmaceuticals Logo icon format

### Ampio Pharmaceuticals Logo icon format Download PNG (55.3 KB)

![Ampio Pharmaceuticals Logo icon format Download PNG (55.3 KB)](/img/orig/AMPE-f254e3ae.png)

## About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.

1. Website domain: ampiopharma.com
2. Employees: 18
3. Marketcap: $3.53 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
